Contact

Representative before the EPO

Employment test 11 - 50 employees
Company dna ernest gutmann yves plasseraud sas
operating since 1985
Headquarter in Paris and 2 offices
active in Legal Services and IP Consulting

Carole Sellin has worked on the following 21 EPO patent applications which have been published in the last five years:

EP11728750

DOUBLE STRANDED RNA COMPOUNDS TO RHOA AND USE THEREOF

IPC classification:
A61K 31/713, C12N 15/113
Applicant:
Quark Pharmaceuticals Inc
Agent:
Carole Sellin, Ernest Gutmann - Yves Plasseraud SAS (EGYP)
Status:
PATENT GRANTED
EP12708475

OLIGONUCLEOTIDE MODULATORS OF THE TOLL-LIKE RECEPTOR PATHWAY

IPC classification:
C12N 15/113
Applicant:
Quark Pharmaceuticals Inc
Agent:
Carole Sellin, Ernest Gutmann - Yves Plasseraud SAS (EGYP)
Status:
PATENT GRANTED
EP12718691

CAPSICUM ROOTSTOCK

IPC classification:
A01H 5/00
Agent:
Carole Sellin, Ernest Gutmann - Yves Plasseraud SAS (EGYP)
Status:
GRANT OF PATENT INTENDED
EP12722443

MOLECULAR SIGNATURE FOR SKIN PIGMENT SPOTS, WHICH IS COMBINED WITH THE EXTRACELLULAR MATRIX

IPC classification:
A61K 8/60, A61Q 19/00, A61Q 19/08, C12Q 1/68
Applicant:
L'Oréal
Agent:
Carole Sellin, Ernest Gutmann - Yves Plasseraud SAS (EGYP)
Status:
PATENT GRANTED
EP12737420

METHOD FOR INCREASING THE EFFICIENCY OF DOUBLE-STRAND BREAK-INDUCED MUTAGENSSIS

IPC classification:
C12N 9/22, C12N 15/82
Applicant:
Cellectis SA
Agent:
Hélène Marthe Georgette Leblois-Préhaud, Cabinet Orès
Agent:
Carole Sellin, Ernest Gutmann - Yves Plasseraud SAS (EGYP)
Agent:
Gevers & Orès
Status:
PATENT GRANTED
EP12819429

DOUBLE-STRANDED OLIGONUCLEOTIDE COMPOUNDS FOR TREATING HEARING AND BALANCE DISORDERS

IPC classification:
A61K 31/7088, C07H 21/00, C12N 15/113
Applicant:
Quark Pharmaceuticals Inc
Agent:
Carole Sellin, Ernest Gutmann - Yves Plasseraud SAS (EGYP)
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13305205

Resistance to arthropod pest in tomatoes

IPC classification:
C12N 15/82
Agent:
Carole Sellin, Ernest Gutmann - Yves Plasseraud SAS (EGYP)
Status:
EXAMINATION IN PROGRESS
EP12788061

METHODS AND COMPOSITIONS FOR TREATING DISEASES, DISORDERS OR INJURY OF THE NERVOUS SYSTEM

IPC classification:
A61K 31/713, A61P 25/00, A61P 27/00, C07K 16/18, C07K 16/40, C12N 15/113
Applicant:
Quark Pharmaceuticals Inc
Agent:
Carole Sellin, Ernest Gutmann - Yves Plasseraud SAS (EGYP)
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12823110

ENDO180-TARGETED PARTICLES FOR SELECTIVE DELIVERY OF THERAPEUTIC AND DIAGNOSTIC AGENTS

IPC classification:
A61K 47/48, A61P 35/00
Applicant:
Ramot at Tel-Aviv University Ltd.
Agent:
Carole Sellin, Ernest Gutmann - Yves Plasseraud SAS (EGYP)
Status:
GRANT OF PATENT INTENDED
EP13706759

DOUBLE-STRANDED RNA COMPOUNDS TO CASP2 AND USES THEREOF

IPC classification:
A61K 31/713, A61P 27/02, C12N 15/113
Applicant:
Quark Pharmaceuticals Inc
Agent:
Carole Sellin, Ernest Gutmann - Yves Plasseraud SAS (EGYP)
Status:
GRANT OF PATENT INTENDED
EP12306208

A nod2-dependant pathway of cytoprotection of stem cells

IPC classification:
A61K 38/05, C12N 5/074, G01N 33/50
Agent:
Carole Sellin, Ernest Gutmann - Yves Plasseraud SAS (EGYP)
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13702123

COMBINATION THERAPY FOR TREATING HEARING AND BALANCE DISORDERS

IPC classification:
A61K 31/713, A61P 27/16, C12N 15/113
Applicant:
Quark Pharmaceuticals Inc
Agent:
Carole Sellin, Ernest Gutmann - Yves Plasseraud SAS (EGYP)
Status:
EXAMINATION IN PROGRESS
EP13733463

THERAPEUTIC OLIGONUCLEOTIDES COMPRISING PYRAZOLOTRIAZINE NUCLEOTIDE ANALOGUES

IPC classification:
A61K 31/712, C07D 251/72, C12N 15/113
Agent:
Carole Sellin, Ernest Gutmann - Yves Plasseraud SAS (EGYP)
Status:
GRANT OF PATENT INTENDED
EP14195359

Compositions and methods for treating diseases, disorders or injury of the CNS

IPC classification:
A61K 31/713, A61P 27/02, C12N 15/113
Applicant:
Quark Pharmaceuticals Inc
Agent:
Carole Sellin, Ernest Gutmann - Yves Plasseraud SAS (EGYP)
Status:
GRANT OF PATENT INTENDED
EP13779756

A NOD2-DEPENDENT PATHWAY OF CYTOPROTECTION OF STEM CELLS

IPC classification:
A61K 38/05, C12N 5/074
Applicant:
Institut Pasteur
Agent:
Carole Sellin, Ernest Gutmann - Yves Plasseraud SAS (EGYP)
Status:
EXAMINATION IN PROGRESS
EP14706037

RESISTANCE TO ARTHROPOD PEST IN TOMATOES

IPC classification:
C12N 15/82
Agent:
Carole Sellin, Ernest Gutmann - Yves Plasseraud SAS (EGYP)
Status:
EXAMINATION REQUESTED
EP14744471

MODIFIED DIATOMS FOR BIOFUEL PRODUCTION

IPC classification:
C12N 1/13, C12N 9/02, C12N 9/04, C12N 9/10, C12N 9/12, C12N 9/16, C12N 15/79, C12P 7/64, C12R 1/89
Applicant:
Cellectis SA
Agent:
Zacco Denmark A/S
Agent:
Carole Sellin, Ernest Gutmann - Yves Plasseraud SAS (EGYP)
Status:
EXAMINATION IN PROGRESS
EP14756127

SPHINGOLIPID-POLYALKYLAMINE-OLIGONUCLEOTIDE COMPOUNDS

IPC classification:
A61K 47/48, A61P 35/00, C12N 15/11
Agent:
Carole Sellin, Ernest Gutmann - Yves Plasseraud SAS (EGYP)
Status:
GRANT OF PATENT INTENDED
EP14812222

CAS9 NUCLEASE PLATFORM FOR MICROALGAE GENOME ENGINEERING

IPC classification:
C12N 9/22, C12N 15/09
Applicant:
Cellectis SA
Agent:
Carole Sellin, Ernest Gutmann - Yves Plasseraud SAS (EGYP)
Status:
EXAMINATION REQUESTED
EP15706016

RESISTANCE TO GEMINIVIRUSES IN WATERMELONS

IPC classification:
A01H 5/08
Agent:
Carole Sellin, Ernest Gutmann - Yves Plasseraud SAS (EGYP)
Status:
EXAMINATION REQUESTED
EP15307186

RESISTANCE TO TOLCNDV IN MELONS

IPC classification:
A01H 1/04, A01H 5/10, C12Q 1/68
Agent:
Carole Sellin, Ernest Gutmann - Yves Plasseraud SAS (EGYP)
Status:
APPLICATION PUBLISHED

Please Sign in to use this feature